NCT01871844View on ClinicalTrials.gov

ITF2984 Repeated Doses Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

May 31, 2013

Conditions

Healthy Male Volunteers

Interventions

DRUG

ITF2984 (500, 1000, 2000 mcg bid for 7 days)

DRUG

octreotide 50 mcg tid

DRUG

Placebo

Trial Locations (2)

Unknown

Centro Ricerche Cliniche, Verona

NG116JS

Quotient Clinical, Ruddington

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Italfarmaco

INDUSTRY